Mainstream

Generic Drugmakers Could See Negative Impact From Higher Chinese Tariffs

Generic drugmakers could see negative impact from higher Chinese tariffs

Generic drugmakers could see negative impact from higher Chinese tariffs

Post Contentvtrs, teva, mrk, lly, pfe, sdzny, sdzxfRead More

You might also be interested in reading RadNet raises 2025 revenue and EBITDA guidance as advanced imaging and AI initiatives accelerate.

March 4, 2025
In Mainstream